Bill > HR5485

This bill, known as the "Second Chance at Life Act of 2025", requires abortion providers performing chemical abortions (using drugs like mifepristone and misoprostol) to provide specific informed consent information to women. Providers must inform women at least 24 hours before the procedure that it may be possible to reverse the effects of a mifepristone-induced abortion if they change their mind, and that time is critical in attempting such a reversal. The bill mandates that providers give written discharge instructions explaining that mifepristone might not always be effective in ending a pregnancy and that reversing the abortion may be possible if the second pill has not been taken. Additionally, the bill requires healthcare facilities to post signs informing patients about potential abortion reversal and directs the Department of Health and Human Services to create and maintain a website with information about abortion pill reversal. The bill also establishes civil remedy provisions, allowing women, fathers, or parents to sue abortion providers who do not comply with these requirements, with potential for actual and punitive damages. There is an exception for medical emergencies where the mother's life is at risk, and the bill does not preempt state laws that might have more extensive disclosure requirements.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/5485/all-info